StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
90
Publishing Date
2021 - 03 - 11
90
Sector
Commercial services
5
Consumer services
1
Finance
2
Health services
3
Health technology
75
Manufacturing
2
Producer manufacturing
1
Technology services
1
Tags
Acquisition
1
Alcohol use disorder
1
Alliances
1
Antibody
2
Application
1
Approval
1
Asia
2
Audio
1
Authorized
1
Bentracimab
1
Bio-nc
1
Biocanada
3
Biocapital
2
Bioforest
1
Biomidwest
4
Biopharma
3
Bioscience
4
Biotech-bay
7
Biotech-beach
10
Cancer
6
Ceo
1
Clinical-trials-phase-iii
1
Collaboration
1
Commercialization
1
Conference
7
Correlation
1
Covid
6
Covid-19
2
Crv431
1
Defense
1
Designation
3
Device
1
Drug
3
Earnings
16
Events
12
Expansion
2
Financial results
24
Gene therapies
2
Gene therapy
2
Genetown
2
Grant
2
Granted
2
Lone-star-bio
5
Nash
2
Offering
3
People
5
Pharm-country
3
Pharma
4
Phase 2
2
Pre-clinical
3
Preclinical
3
Presentation
4
Product-news
9
Research
9
Response
2
Results
27
Therapeutics
3
Therapy
3
Treatment
4
Trial
3
Entities
89bio, inc.
1
Abbott laboratories
1
Actinium pharmaceuticals, inc.
1
Adc therapeutics sa
1
Aerie pharmaceuticals, inc.
2
Aeterna zentaris inc.
1
Agex therapeutics, inc.
1
Akebia therapeutics, inc.
1
Aldeyra therapeutics, inc.
1
Alnylam pharmaceuticals, inc.
2
Alpine immune sciences, inc.
1
Amgen inc.
2
Annovis bio, inc.
2
Applied dna sciences, inc.
1
Artelo biosciences, inc.
1
Atyr pharma, inc.
1
Bicycle therapeutics plc
1
Biohaven pharmaceutical holding company ltd.
1
Biovie inc.
1
Bioxcel therapeutics, inc.
2
Bristol-myers squibb company
1
Cardiff oncology, inc.
1
Centene corporation
1
Cymabay therapeutics inc.
1
Danaher corporation
1
Eli lilly and company
2
Entera bio ltd.
1
Exelixis, inc.
1
Exicure, inc.
2
Freeline therapeutics holdings plc
1
Galera therapeutics, inc.
1
Galmed pharmaceuticals ltd.
1
Geron corporation
1
Gilead sciences, inc.
1
Gossamer bio, inc.
1
Greenwich lifesciences, inc.
2
Hepion pharmaceuticals, inc.
1
Hercules capital, inc.
1
Hillenbrand inc
1
Horizon therapeutics public limited company
1
I-mab
1
Ibio, inc.
1
Ideaya biosciences, inc.
1
Idex corporation
1
Illumina, inc.
1
Immunitybio inc
1
Invitae corporation
1
Invo bioscience inc.
1
Johnson & johnson
1
Kezar life sciences, inc.
1
Kymera therapeutics, inc.
1
Lexaria bioscience corp
1
Lineage cell therapeutics, inc.
3
Lumos pharma, inc.
1
Marker therapeutics, inc.
1
Medicenna therapeutics corp.
1
Mersana therapeutics, inc.
1
Morgan stanley
1
Nemaura medical inc.
1
Sanofi
2
Symbols
ABT
1
ADCT
1
AERI
2
AEZS
1
AGE
1
AKBA
1
ALDX
1
ALNY
2
ALPN
1
AMGN
2
ANVS
2
APDN
1
ARTL
1
ATNM
1
BCYC
1
BHVN
1
BIVI
1
BMY
1
BTAI
2
CBAY
1
CNC
1
CRDF
1
DHR
1
ENTX
1
ETNB
1
EXEL
1
FRLN
1
GERN
1
GILD
1
GLMD
1
GLSI
2
GOSS
1
GRTX
1
HEPA
1
HI
1
HTGC
1
HZNP
1
IBIO
1
IBRX
1
IDYA
1
IEX
1
ILMN
1
IMAB
1
INVO
1
JNJ
1
KYMR
1
KZR
1
LCTX
3
LEXX
1
LIFE
1
LLY
2
LUMO
1
MDNA
1
MRKR
1
MRSN
1
MS
1
NMRD
1
NUVB
1
SNY
2
XCUR
2
Exchanges
Amex
7
Nasdaq
72
Nyse
16
Crawled Date
2023 - 04 - 27
91
2023 - 04 - 26
83
2023 - 04 - 17
79
2023 - 02 - 23
78
2023 - 02 - 07
87
2023 - 01 - 09
90
2022 - 11 - 10
81
2022 - 11 - 03
94
2022 - 11 - 01
113
2022 - 08 - 11
85
2022 - 08 - 09
80
2022 - 08 - 04
113
2022 - 08 - 03
76
2022 - 08 - 02
81
2022 - 08 - 01
83
2022 - 07 - 28
80
2022 - 07 - 26
88
2022 - 05 - 11
92
2022 - 05 - 10
87
2022 - 05 - 09
85
2022 - 05 - 05
78
2022 - 05 - 04
86
2022 - 05 - 02
88
2022 - 04 - 28
92
2022 - 04 - 27
81
2022 - 04 - 25
79
2022 - 03 - 03
83
2022 - 03 - 01
96
2022 - 02 - 28
86
2022 - 02 - 03
77
2022 - 01 - 18
82
2022 - 01 - 06
123
2022 - 01 - 05
81
2022 - 01 - 04
118
2021 - 12 - 13
100
2021 - 11 - 11
96
2021 - 11 - 10
88
2021 - 11 - 09
94
2021 - 11 - 08
77
2021 - 11 - 05
87
2021 - 11 - 04
106
2021 - 11 - 03
76
2021 - 10 - 28
89
2021 - 10 - 26
92
2021 - 09 - 20
92
2021 - 09 - 09
91
2021 - 08 - 05
91
2021 - 08 - 03
78
2021 - 05 - 26
76
2021 - 05 - 17
76
2021 - 05 - 10
78
2021 - 05 - 05
78
2021 - 05 - 03
92
2021 - 04 - 27
89
2021 - 04 - 26
79
2021 - 04 - 22
76
2021 - 04 - 20
90
2021 - 04 - 13
89
2021 - 03 - 15
86
2021 - 03 - 11
90
Crawled Time
06:00
1
08:00
1
09:00
2
12:00
2
13:00
15
13:01
11
14:00
12
14:01
6
14:02
5
14:18
2
14:19
3
14:32
4
15:02
1
16:01
1
16:02
2
17:00
2
17:01
1
17:02
3
22:00
1
22:01
1
22:03
3
22:04
1
23:02
2
23:03
8
Source
feed.businesswire.com
2
galmedpharma.com
10
investor.alkermes.com
1
investor.aveooncology.com
1
ir.biolinerx.com
2
ir.kalvista.com
1
ir.plxpharma.com
1
ir.vaccinex.com
1
spacfeed.com
5
www.biospace.com
90
www.fda.gov
2
www.globenewswire.com
123
www.prnewswire.com
113
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
crawled date :
2021 - 03 - 11
source :
Www.biospace.com
save search
Lumos Pharma to Participate in March 2021 Investor Conferences
Published:
2021-03-11
(Crawled : 23:03)
- biospace.com/
LUMO
|
$2.79
4.1%
3.94%
17K
|
Health Technology
|
-78.87%
|
O:
1.89%
H:
4.82%
C:
0.0%
conference
pharma
Salarius Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial ResultsConference Call and Live Audio Webcast Scheduled for Thursday, March 18, 2021, 4:30 p.m. ET
Published:
2021-03-11
(Crawled : 23:03)
- biospace.com/
SLRX
|
$0.5118
1.18%
16K
|
Commercial Services
|
-66.44%
|
O:
0.67%
H:
4.67%
C:
4.67%
financial results
results
audio
Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020
Published:
2021-03-11
(Crawled : 23:03)
- biospace.com/
PSTX
|
$2.15
-0.23%
-0.23%
420K
|
Health Technology
|
-77.96%
|
O:
0.82%
H:
4.76%
C:
-0.81%
financial results
results
program
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Published:
2021-03-11
(Crawled : 23:03)
- biospace.com/
LCTX
|
$1.14
0.0%
330K
|
Health Technology
|
-49.33%
|
O:
1.33%
H:
5.26%
C:
2.63%
AGE
A
|
$11.1
0.0%
3.8K
|
Health Technology
|
416.28%
|
O:
0.0%
H:
0.47%
C:
-5.58%
financial results
results
Zosano Pharma Reports Fourth Quarter and Fiscal Year 2020 Financial Results
Published:
2021-03-11
(Crawled : 23:03)
- biospace.com/
ZSAN
|
$0.5576
7.23%
-5.85%
|
Health Technology
|
-98.63%
|
O:
0.86%
H:
9.4%
C:
7.69%
financial results
results
pharma
Amgen To Present At The Oppenheimer 31st Annual Healthcare Conference
Published:
2021-03-11
(Crawled : 23:03)
- biospace.com/
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
18.95%
|
O:
0.3%
H:
1.43%
C:
0.22%
conference
presentation
Alpine Immune Sciences to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
Published:
2021-03-11
(Crawled : 23:03)
- biospace.com/
ALPN
|
$64.535
-0.07%
-0.07%
3.1M
|
Health Technology
|
422.67%
|
O:
0.08%
H:
6.31%
C:
5.58%
financial results
results
Neovasc Announces Fourth Quarter and Fiscal Year 2020 Financial Results
Published:
2021-03-11
(Crawled : 23:03)
- biospace.com/
NVCN
|
$30.03
1.66%
-2.02%
0
|
Health Technology
|
2321.77%
|
O:
4.03%
H:
9.9%
C:
4.65%
financial results
results
Venus Concept Inc. to Participate in Two Upcoming Investor Conferences on March 17th
Published:
2021-03-11
(Crawled : 23:02)
- biospace.com/
VERO
|
$0.787
-6.79%
-7.28%
19K
|
Health Technology
|
-68.85%
|
O:
1.64%
H:
4.84%
C:
4.84%
Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit Dry Eye Innovation Showcase
Published:
2021-03-11
(Crawled : 23:02)
- biospace.com/
AERI
|
$15.25
0.0%
|
Health Technology
|
-22.34%
|
O:
0.87%
H:
3.99%
C:
2.98%
dry eye
eye
Entera Bio to Report Financial Results for the Year Ended December 31, 2020 on March 18, 2021
Published:
2021-03-11
(Crawled : 22:04)
- biospace.com/
ENTX
|
$2.22
8.29%
7.66%
110K
|
Health Technology
|
38.75%
|
O:
190.63%
H:
69.25%
C:
-13.12%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
18.95%
|
O:
0.3%
H:
1.43%
C:
0.22%
financial results
results
Neuronetics Announces Retirement of Gregory Harper, Vice President, R&D and Clinical
Published:
2021-03-11
(Crawled : 22:03)
- biospace.com/
STIM
|
$3.865
3.34%
3.23%
41K
|
Health Technology
|
-73.18%
|
O:
2.57%
H:
1.9%
C:
1.76%
Illumina and Harvard Pilgrim Health Care Real-World Evidence Study Demonstrates Cost-Effectiveness of Offering NIPT to All Pregnant Women
Published:
2021-03-11
(Crawled : 22:03)
- biospace.com/
ILMN
|
$124.41
3.46%
3.34%
1.3M
|
Health Technology
|
-68.84%
|
O:
1.78%
H:
2.91%
C:
1.55%
offering
women
Kezar Life Sciences Reports Fourth Quarter and Year End 2020 Financial Results and Provides Business Updates
Published:
2021-03-11
(Crawled : 22:03)
- biospace.com/
KZR
|
$0.8232
0.15%
0.15%
520K
|
Health Technology
|
-87.13%
|
O:
-0.16%
H:
2.02%
C:
1.86%
financial results
results
life science
Geron Corporation Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Published:
2021-03-11
(Crawled : 22:01)
- biospace.com/
GERN
|
$3.495
-6.3%
-6.72%
10M
|
Health Technology
|
91.26%
|
O:
1.64%
H:
2.09%
C:
1.61%
LCTX
|
$1.14
0.0%
330K
|
Health Technology
|
-49.33%
|
O:
1.33%
H:
5.26%
C:
2.63%
financial results
results
Marker Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
Published:
2021-03-11
(Crawled : 22:00)
- biospace.com/
MRKR
|
$4.43
5.73%
5.42%
12K
|
Consumer Services
|
76.1%
|
O:
0.0%
H:
2.39%
C:
0.8%
offering
therapeutics
publication
ImmunityBio Announces Novel ACE2 Decoy COVID-19 Therapeutic that Shows High Binding to SARS-CoV-2 Variants and Neutralizes Live Viruses
Published:
2021-03-11
(Crawled : 17:02)
- biospace.com/
IBRX
|
$5.48
10.93%
9.85%
31M
|
Manufacturing
|
-85.81%
|
O:
5.51%
H:
0.0%
C:
-16.66%
covid
sars-cov-2
Persephone Biosciences Initiates VOICES Study of Gut Microbiome's Correlation to Immune Response in COVID-19 Vaccination
Published:
2021-03-11
(Crawled : 17:02)
- biospace.com/
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-6.03%
|
O:
0.25%
H:
0.68%
C:
-0.25%
covid
correlation
vaccine
response
covid-19
bioscience
Annovis Bio Signs GMP Manufacturing Agreement to Support Planned Late- Stage Studies
Published:
2021-03-11
(Crawled : 17:02)
- biospace.com/
ANVS
|
$11.88
3.39%
0.0%
230K
|
Health Technology
|
-54.54%
|
O:
6.01%
H:
2.89%
C:
2.45%
IDT Acquires Swift Biosciences, a Pioneer in the Development of Next-Generation Sequencing (NGS) Library Preparation Genomics Kits for Academic, Translational, and Clinical Research
Published:
2021-03-11
(Crawled : 17:01)
- biospace.com/
DHR
|
$253.11
7.21%
0.0%
6.8M
|
Health Technology
|
18.87%
|
O:
1.37%
H:
1.93%
C:
1.57%
genomic
research
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.